Clinical trial Recruiting at 1 site Observational Ages 1 Hour to 90

Registry for inherited ventricular arrhythmias in China

Official title: China Inherited Ventricular Arrhythmias Registry, a Multicenter, Observational and Prospective Study

Run by China National Center for Cardiovascular Diseases · NCT03880708 · Data updated 2026-11-12

This study is trying to understand how genetic factors affect dangerous heart rhythm problems in people with inherited conditions like Brugada syndrome and Long QT syndrome by collecting health information from 500 participants across China.

Quick facts

Study typeObservational
Ages1 Hour to 90 Years
SexAll
Enrollment500 (estimated)
SponsorChina National Center for Cardiovascular Diseases
Government
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 24, 2017
Main results expectedOctober 24, 2022
Study endsOctober 24, 2027
Registry record updatedMarch 26, 2019
Trial IDNCT03880708 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Brugada syndrome, Long QT syndrome, Short QT syndrome, Early repolarization syndrome, or Catecholaminergic polymorphic ventricular tachycardia.

Probably not a fit

Patients currently enrolled in other clinical trials may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, prospective, multi-center registry aims to build a risk stratification for malignant inherited ventricular arrhythmias, including conditions like Brugada syndrome and Long QT syndrome. The study will recruit 500 participants from 10 centers across China, collecting clinical data from medical records and blood samples for genetic analysis. Participants will be followed up every six months to monitor their condition and treatment outcomes. The goal is to explore the correlation between genotype and phenotype to aid in molecular diagnosis and risk stratification.

Why it matters

Potential benefit: If successful, this study could lead to improved risk assessment and management strategies for patients with inherited ventricular arrhythmias.

How similar studies have gone: Other studies have shown success in similar approaches to risk stratification and genetic analysis in inherited arrhythmias, indicating a promising avenue for this research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosed as Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) or Catecholaminergic polymorphic ventricular tachycardia(CPVT).

Exclusion Criteria:

* patients were enrolled by other clinical trials.

Where it's running

  • China National Center for Cardiovascular Diseases
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.